Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

694 public trials 105 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Completed

Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)

NCT02953301

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Medizinische Universität Graz Graz, Austria
  • Medizinische Universität Wien Vienna, Austria
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Universitaire Ziekenhuizen Leuven, Belgium
View all 54 locations
View Trial Details
Completed

AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHL

NCT05140382

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Hackensack, New Jersey, United States
  • Research Site Houston, Texas, United States
View all 27 locations
View Trial Details
Completed

Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas

NCT01793233

Conditions
Anaplastic Large Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +21 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 107 locations
View Trial Details
Completed

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

NCT02576496

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Cutaneous T Cell Lymphoma, +23 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Cancer Center Jacksonville, Florida, United States
  • Columbia University Medical Center New York, United States
  • University Hospitals Cleveland Seidman Cancer Center Cleveland, Ohio, United States
View all 18 locations
View Trial Details
Completed

A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation

NCT03942263

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
Locations
  • State budgetary healthcare institution of the Astrakhan region Alexander-Mariinsky regional clinical hospital Astrakhan, Russia
  • Autonomous Institution "Republican Clinical Oncology Dispensary" of the Ministry of Health of Chuvashia Cheboksary, Russia
  • State budgetary health care institution "Chelyabinsk Regional Clinical Center for Oncology and Nuclear Medicine" Chelyabinsk, Russia
  • State Budget Public Health Institution "Regional Oncological Dispensary" Irkutsk, Russia
View all 50 locations
View Trial Details
Completed

Investigation of Tipifarnib in Treatment of Subjects With Peripheral T-Cell Lymphoma (PTCL) That Have Not Responded to Standard Therapy

NCT02464228

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 13 locations
View Trial Details

Related conditions